Data

PQT EMA Data

University of Tasmania, Australia
Stuart Ferguson
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=https://data.utas.edu.au/metadata/dbc8eefe-42b5-4093-bb4f-ce4a4a1d7665&rft.title=PQT EMA Data&rft.identifier=https://data.utas.edu.au/metadata/dbc8eefe-42b5-4093-bb4f-ce4a4a1d7665&rft.publisher=University of Tasmania, Australia&rft.description=The objective of the current study was to test the effects of the pre-quit use of varenicline and nicotine patch on smoking rate and satisfaction with smoking. Methods: All participants were required to attend up to five study visit sections. Participants (n = 213) who were interested in quitting were randomised (open-label) to receive either prequit patch or varenicline (both treatments started 2 weeks prior to an assigned quit day, followed by 10 weeks post-quit) or standard patch (10 weeks starting from an assigned quit day). Participants used modified smartphones to monitor their smoking in real time for 4 weeks.&rft.creator=Stuart Ferguson &rft.date=2018&rft.relation=10.1007/s00213-017-4604-y&rft_rights=Attribution - NonCommercial - Share Alike(BY - NC - SA) http://creativecommons.org/licenses/by-nc-sa/4.0/&rft_subject=Preventative health care&rft_subject=Public health&rft_subject=HEALTH SCIENCES&rft_subject=Preventive medicine&rft_subject=Public health (excl. specific population health)&rft_subject=HEALTH&rft_subject=smoking&rft_subject=cessation&rft_subject=nicotine&rft_subject=dependence&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

Non-Commercial Licence view details
CC-BY-NC-SA

Attribution - NonCommercial - Share Alike(BY - NC - SA)
http://creativecommons.org/licenses/by-nc-sa/4.0/

Access:

Open

Full description

The objective of the current study was to test the effects of the pre-quit use of varenicline and nicotine patch on smoking rate and satisfaction with smoking.

Methods: All participants were required to attend up to five study visit sections. Participants (n = 213) who were interested in quitting were randomised (open-label) to receive either prequit patch or varenicline (both treatments started 2 weeks prior to an assigned quit day, followed by 10 weeks post-quit) or standard patch (10 weeks starting from an assigned quit day). Participants used modified smartphones to monitor their smoking in real time for 4 weeks.

This dataset is part of a larger collection

Click to explore relationships graph
Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover